Skip Navigation

Master Screening and Reassessment Protocol MSRP for Tier Advancement in the NCI myeloMATCH Clinical Trials

Brief Summary

Type:
Leukemias

Study Type:
Screening

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT05564390

Study #:
STUDY00160782

Start Date:
Aug 04, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05564390

View Complete Trial Details & Eligibility at ClinicalTrials.gov